Touchstone International Medical Science Co., Ltd.

SSE:688013.SS

26.88 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income 0013.917.49911.35219.5496.52214.8911.711.40312.66911.8557.2685.0711.48511.92512.948.8769.78110.2836.0087.39713.13810.73510.735
Depreciation & Amortization 0002.5472.5479.717-5.2782.6872.6872.3772.3771.8431.8431.8111.8111.8081.8086.544-3.0913.09105.543000
Deferred Income Tax 00000018.6791.0770-0.39413.734-12.60000000000000
Stock Based Compensation 0008.351020.003-9.1969.196017.505-10.32810.328018.227-4.3754.375000000000
Change In Working Capital 000-9.613019.922-4.8494.8490-10.6146.887-6.887016.125-0.3210.3210-0.8514.015-4.0150-8.686000
Accounts Receivables 000-8.9270-4.238-3.9383.9380-2.9241.185-1.1850-4.3051.319-1.3190-1.5331.815-1.81500.494000
Change In Inventory 000-9.03704.158-0.9110.9110-7.6915.701-5.7010-0.1443.505-3.50500.9032.2-2.20-9.18000
Change In Accounts Payables 0000009.196-9.1960-20.08111.76-11.760000000000000
Other Working Capital 0008.351020.003-9.1969.196020.081-11.7611.76020.575-5.1455.1450-0.220000000
Other Non Cash Items 006.138-3.205-2.559-2,019.8794.077-11.77-2.687-11.403-12.6697.3152.28218.561-11.485-11.925-12.94-8.876-9.781-10.283-6.008-7.397-13.138-4.933-4.933
Operating Cash Flow 0020.03811.7478.79333.7599.95520.92911.711.40312.66911.8559.5521.81918.23815.18816.20612.20214.4113.7751.6968.06715.155.8025.802
Investing Activities:
Investments In Property Plant And Equipment -15.299-12.042-3.05-21.537-5.312-9-3.474-4.249-1.687-40.417-1.323-4.674-1.256-5.039-1.564-1.089-1.517-1.714-2.113-1.287-2.179-1.877-3.81-1.862-1.862
Acquisitions Net 0000000-128.8410-000001.7641.0352.0131.7532.1131.3752.17903.90900
Purchases Of Investments -253.063-378.567-312.684-270.9-154.8-94-98.38-109.05-246-323-393.2-290.35-306-336.5-359.5-347-255-414-106.18-9-50-7.800
Sales Maturities Of Investments 241.171437.194259.421132.933173.6104.03292.644237.891229.248193.629387.2352.687397.411344.249348.974340.355172.396270.1180.09511.8142.2157.833-0.00400
Other Investing Activites 0.068.54-1.424-018.810.032-0128.841-0000.06291.4110-1.564-1.089-1.517-1.714-2.113-1.287-2.1790.055-3.811.6691.669
Investing Cash Flow -27.1355.125-57.737-159.50413.4881.032-9.211124.592-18.44-169.788-7.32357.72490.1552.709-11.891-7.788-83.626-145.556-108.1981.615-4.9646.01-11.514-0.194-0.194
Financing Activities:
Debt Repayment 20.08000000008.695000000000000-2200
Common Stock Issued 00000000014.816-13.98313.9830000000000000
Common Stock Repurchased 0035.989-35.9890000.184-0.184-14.816-31.501-10-8.759000000000000
Dividends Paid -39.588-38.176000-19.802-1.067-18.7340-0.135-0.831-14.972-0.007-16-16-16000000-0.136-10.306-10.306
Other Financing Activities 14.417-1.935-4.23626.582-35.893-0.045-0.232-3.3940-25.352-15.2013.983-8.76616-1600-5.372326.566000-06.56.5
Financing Cash Flow -5.09-40.11-4.23626.582-35.893-0.045-1.299-3.21-0.184-31.608-16.032-10.989-8.76600-160-5.372326.566000-22.136-3.806-3.806
Other Information:
Effect Of Forex Changes On Cash 1.55-0.4120.676-0.4280.2081.7330.2280.2430.0944.499-0.0380.327-0.9280.7111.3381.5340.670.3260.190.860.3910.3110.5040.4430.443
Net Change In Cash -17.5429.491-41.259-122.236-13.40436.479-0.326142.555-0.227-191.831-7.19266.64590.01122.494.712-10.42-68.145-138.4232.96816.25-2.87814.388-17.9962.2462.246
Cash At End Of Period 46.58664.12634.63575.894198.13211.534175.055175.38132.82533.052224.883232.075165.4375.41852.92848.21658.636126.782265.18232.21315.96418.8414.45322.4492.246